Literature DB >> 16338649

Endoscopic therapy of early gastric cancer.

Hironori Yamamoto1, Hiroto Kita.   

Abstract

Endoscopic therapy of early gastric cancer is applicable for differentiated-type mucosal carcinomas that have an extremely low potency of lymph-node metastasis. Among various kinds of endoscopic therapy, endoscopic mucosal resection is the most recommended procedure, because pathological evaluation of affected tissues is available using this method. Recently, endoscopic submucosal dissection, a novel method of endoscopic mucosal resection, has gained interest as a more reliable therapeutic procedure. In the present chapter several issues will be presented on endoscopic therapy for early gastric cancer, including endoscopic diagnosis of early gastric cancer, currently accepted indications of endoscopic therapy, and the possibility of extending the indication and techniques used for mucosal resection.

Entities:  

Mesh:

Year:  2005        PMID: 16338649     DOI: 10.1016/j.bpg.2005.03.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  17 in total

Review 1.  Magnifying endoscopy in upper gastroenterology for assessing lesions before completing endoscopic removal.

Authors:  Ning-Li Chai; En-Qiang Ling-Hu; Yoshinori Morita; Daisuke Obata; Takashi Toyonaga; Takeshi Azuma; Ben-Yan Wu
Journal:  World J Gastroenterol       Date:  2012-03-28       Impact factor: 5.742

2.  Role of narrow band imaging in endoscopic submucosal dissection.

Authors:  Kouichi Nonaka; Makoto Nishimura; Hiroto Kita
Journal:  World J Gastrointest Endosc       Date:  2012-09-16

Review 3.  Endoscopic treatment for early gastric cancer.

Authors:  Yang Won Min; Byung-Hoon Min; Jun Haeng Lee; Jae J Kim
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

4.  Safety of carbon dioxide insufflation during gastric endoscopic submucosal dissection in patients with pulmonary dysfunction under conscious sedation.

Authors:  Jun Takada; Hiroshi Araki; Fumito Onogi; Takayuki Nakanishi; Masaya Kubota; Takashi Ibuka; Masahito Shimizu; Hisataka Moriwaki
Journal:  Surg Endosc       Date:  2014-10-16       Impact factor: 4.584

5.  Endoscopic submucosal dissection for premalignant lesions and noninvasive early gastrointestinal cancers.

Authors:  Sadettin Hulagu; Omer Senturk; Cem Aygun; Orhan Kocaman; Altay Celebi; Tolga Konduk; Deniz Koc; Goktug Sirin; Ugur Korkmaz; Ali Erkan Duman; Neslihan Bozkurt; Gokhan Dindar; Tan Attila; Yesim Gurbuz; Orhan Tarcin; Cem Kalayci
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

6.  Short term results of endoscopic submucosal dissection in superficial esophageal squamous cell neoplasms.

Authors:  Kouichi Nonaka; Shin Arai; Keiko Ishikawa; Masamitsu Nakao; Yousuke Nakai; Osamu Togawa; Koji Nagata; Michio Shimizu; Yutaka Sasaki; Hiroto Kita
Journal:  World J Gastrointest Endosc       Date:  2010-02-16

7.  Safety and efficacy of carbon dioxide insufflation during gastric endoscopic submucosal dissection.

Authors:  Jun Takada; Hiroshi Araki; Fumito Onogi; Takayuki Nakanishi; Masaya Kubota; Takashi Ibuka; Masahito Shimizu; Hisataka Moriwaki
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

8.  Endoscopic holmium:YAG laser ablation of early gastrointestinal intramucosal cancer.

Authors:  Yongping Mao; Haixia Qiu; Qingsen Liu; Zhongsheng Lu; Kaichun Fan; Yingcai Huang; Yunsheng Yang
Journal:  Lasers Med Sci       Date:  2013-01-18       Impact factor: 3.161

9.  Outcome of segmental gastrectomy versus distal gastrectomy for early gastric cancer.

Authors:  Koichi Ishikawa; Tsuyoshi Arita; Shigeo Ninomiya; Toshio Bandoh; Norio Shiraishi; Seigo Kitano
Journal:  World J Surg       Date:  2007-08-24       Impact factor: 3.352

10.  A genomic approach to investigate expression profiles in Slovenian patients with gastric cancer.

Authors:  Petra Hudler; Stanislav Repše; Robert Juvan; Radovan Komel
Journal:  Oncol Lett       Date:  2011-07-07       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.